Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A Phase 4 Clinical Study to Investigate the Effectiveness and Safety of Skin Resurfacing

NCT: NCT07214272 · ACTIVE_NOT_RECRUITING

NCT IDNCT07214272
StatusACTIVE_NOT_RECRUITING
Start Date2025-10-17
Completion2026-09
SponsorBausch Health Americas, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

This study is a prospective, post-marketing (Phase 4) non-registrational single-arm, open-label, multicenter study.

Frequently Asked Questions

What is A Phase 4 Clinical Study to Investigate the Effectiveness and Safety of Skin Resurfacing?

A Phase 4 Clinical Study to Investigate the Effectiveness and Safety of Skin Resurfacing is a clinical trial registered under NCT07214272. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT07214272?

The current status of NCT07214272 (A Phase 4 Clinical Study to Investigate the Effectiveness and Safety of Skin Resurfacing) is: ACTIVE_NOT_RECRUITING.

When did A Phase 4 Clinical Study to Investigate the Effectiveness and Safety of Skin Resurfacing start?

A Phase 4 Clinical Study to Investigate the Effectiveness and Safety of Skin Resurfacing started on 2025-10-17.

Related Devices

K190342BIAFINE Topical CreamBausch Health Americas Incorporated K242142Fraxel® FTX Laser SystemSolta Medical

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑